ASCLETIS PHARMA INC. - FDA IND SUBMISSION OF ASC39, AN ORAL- SMALL MOLECULE SELECTIVE AMYLIN RECEPTOR AGONIST FOR- TREATMENT OF OBESITY

Reuters · 4d ago

Please log in to view news